Shareholders Equity ratio Analysis of Immunitybio Inc - Deep Dive
Shareholders Equity of IBRX
Dec-23-116.15Very Poor Shareholders Equity | Dec-22-123.45Very Poor Shareholders Equity | Growth5.91% |
Shareholders Equity Analysis of Immunitybio Inc
Shareholders Equity Ratio of IBRX has grown by 5.91 % Compared to previous Financial Year. |
Shareholders Equity Ratio with value of 84.32 was highest in Year Dec-19 in last Five Years. |
Shareholders Equity Ratio with value of -123.45 was lowest in Year Dec-22 in last Five Years. |
Latest Shareholders Equity Ratio with value of -116.15 is lower than Average Shareholders Equity of -25.93 in last five years. |
Other Shareholders Equity Related Info of IBRX that may interest you.
Immunitybio Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
IBRX | 5.96 | 5.87 | 1.53 % | Biotechnology |
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation. more ..Shareholders Equity Related Ratios
DebtToEquityRatio | ReturnOnEquity |
Tsr Stability Index
Poor Stability Stock |
FY - Historical Shareholders Equity of Immunitybio Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Shareholders Equity | -116.15 | -123.45 | -51.65 | 77.30 | 84.32 | 80.25 | 87.38 |
Change | 5.91 % | -139.03 % | -166.81 % | -8.32 % | 5.08 % | -8.17 % | -5.45 % |
FY Chart of Shareholders Equity of Immunitybio Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)